Advance refundings double the stock of tax-exempt bonds for a single project ... Win Smith is the founder of Win Analytics and blogs at The Well-Tempered …
Exelixis (NASDAQ: EXEL) stock had been in the doldrums ... for for HCC indication in the first quarter of 2018. To know why Exelixis' rebound is just getting started, it's important to understand why the stock dipped in the first place.
Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, these can also lead on the downside when the growth story is over, …
Merck carries a Zacks Rank #3 (Hold). A better-ranked stock in the health care sector is Exelixis, Inc. (NASDAQ:EXEL) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. Exelixis’ …
IONS closed Tuesday's trading at $50.93, down 2.60%. In after-hours, the stock gained 1.90% to $51.90. Exelixis Inc.'s (EXEL) supplemental New Drug Application for CABOMETYX as first-line monotherapy for advanced renal cell …
This working stock probably represents a loan of gold that the US Mint ... The same list is also in an Excel spreadsheet here …
"The EXEL Industries Group had a great 2016-2017 in terms of growth, profitability and cash generation. We continue to pursue our objective of sustainable and profitable growth and have reached a new milestone this year, with an operating …